Search Results

Depression and inflammation among epidermal growth factor receptor (EGFR) mutant nonsmall cell lung cancer patients.

• Authors : McFarland, Daniel C. (AUTHOR); Jutagir, Devika R. (AUTHOR); Rosenfeld, Barry (AUTHOR)

Subjects: NON-small-cell lung carcinoma; EPIDERMAL growth factor receptors; CANCER treatment

• Source: Psycho-Oncology. Jul2019, Vol. 28 Issue 7, p1461-1469. 9p. 1 Diagram, 4 Charts.

Record details

Applied Science & Technology Full Text (H.W. Wilson)

Record details

Sacituzumab Govitecan for the Treatment of HR+/HER2-Breast Cancer in Heavily Pre-treated Patients.

• Authors : Lucas, Tylan¹; Chan, Joshua²; Chopra, Neha¹

Subjects: *EPIDERMAL growth factor receptors; *ANTIBODY-drug conjugates; *CANCER treatment

• Source: touchREVIEWS in Oncology & Haematology. 2023, Vol. 19 Issue 2, p12-15. 4p.

Record details

ADC: a deadly killer of platinum resistant ovarian cancer.

• Authors : Cheng, Xu¹ (AUTHOR); Li, Ping¹ (AUTHOR); Jiang, Rongqi¹ (AUTHOR)

Subjects: *EPIDERMAL growth factor receptors; *OVARIAN cancer; *ANTIGEN receptors

• Source: Journal of Ovarian Research. 10/4/2024, Vol. 17 Issue 1, p1-14. 14p.

Record details

Subcutaneous versus intravenous administration of Trastuzumab: a minimization cost analysis with real world data from a reference cancer centre in Peru.

• Authors : Otoya, Iris¹ ; Valdiviezo, Natalia¹; Roque, Katia^1,2

Subjects: *EPIDERMAL growth factor receptors; *COST analysis; *CANCER treatment

• Source: Ecancermedicalscience. 2024, Vol. 18 Issue 1676-1753, p1-12. 12p.

Record details

Young Age as a Predictor of Chemotherapy Recommendation and Treatment in Breast Cancer: A National Cancer Database Study.

• Authors : Graham, Elaina¹ (AUTHOR); Bennett, Katie¹ (AUTHOR); Boselli, Danielle² (AUTHOR)

Subjects: *HORMONE receptor positive breast cancer; *EPIDERMAL growth factor receptors; *BREAST cancerUNITED States

• Source: Journal of Surgical Research. Apr2024, Vol. 296, p155-164. 10p.

Record details

Practical solutions to epidermal growth factor receptor tyrosine kinase inhibitor dose modifications in resource-constrained settings: Thinking outside the (packaging) box.

• Authors : Singh, N.¹ ; Prasad, K. T.¹

Subjects: *EPIDERMAL growth factor receptors; *CANCER treatment; *NON-small-cell lung carcinoma

• Source: Indian Journal of Cancer. Jan-Mar2017, Vol. 54 Issue 1, p186-187. 2p.

Record details

ASCO 2024: Advances in lung cancer treatments and care: A new standard of care therapy based on the results of the LAURA study underscores the need for testing for epidermal growth factor receptor (EGFR) mutations in patients with unresectable stage III lung cancer

• Authors : Nierengarten, Mary Beth (AUTHOR)

Subjects: *EPIDERMAL growth factor receptors; *ANDROGEN deprivation therapy; *RADICAL prostatectomy

• Source: Cancer (0008543X). Sep2024, Vol. 130 Issue 17, p2894-2894. 1p.

Record details

Trends in Presentation, Management, and Survival of Women With Breast Cancer in a Multiethnic, Middle-Income Asian Setting.

• Authors : Jaya-Prakason, Sharminii¹ (AUTHOR); Kong, Yek-Ching¹ (AUTHOR); Yip, Cheng-Har² (AUTHOR)

Subjects: *EPIDERMAL growth factor receptors; *MALAYSIANS; *HORMONE receptors

• Source: JCO Global Oncology. 8/1/2024, Vol. 10, p1-15. 15p.

Record details

Cancer-associated fibroblasts mediate resistance to anti-EGFR therapies in cancer.

• Authors : Dai, Shuang^1,2 (AUTHOR); Liu, Yingtong^1,3 (AUTHOR); Liu, Zheran⁴ (AUTHOR)

Subjects: *EPIDERMAL growth factor receptors; *FIBROBLASTS; *CANCER treatment

• Source: Pharmacological Research. Aug2024, Vol. 206, pN.PAG-N.PAG. 1p.

Record details